JAK2 V617F stimulates proliferation of erythropoietin-dependent erythroid progenitors and delays their differentiation by activating Stat1 and other nonerythroid signaling pathways
JAK2 V617F is a mutant-activated JAK2 kinase found in most polycythemia vera (PV) patients; it skews normal proliferation and differentiation of hematopoietic stem and progenitor cells and simulates aberrant expansion of erythroid progenitors. JAK2 V617F is known to activate some signaling pathways...
Main Authors: | , , , |
---|---|
Other Authors: | |
Format: | Article |
Published: |
Elsevier
2018
|
Online Access: | http://hdl.handle.net/1721.1/116735 https://orcid.org/0000-0002-7029-7415 |